GlassScriptPhysician profile
Reena T Doane
NPI 1982638235
$2,195.29
in general payments reported to CMS, 2019-2025
22 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.15 · 2022: $398 · 2023: $787 · 2024: $431 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,698 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,698.42 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $470.50 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $461.53 | 2022-2025 | Erleada, Akeega |
| Axonics, INC. | $147.59 | 2023 | Axonics |
| Medtronic, INC. | $129.89 | 2023-2024 | Interstim |
| Novartis Pharmaceuticals Corporation | $120.14 | 2024-2025 | |
| Blue Earth Diagnostics | $115.11 | 2023-2024 | |
| Urogen Pharma, INC. | $105.95 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $88.32 | 2023-2024 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $81.38 | 2024 | |
| Myriad Genetic Laboratories, INC. | $76.08 | 2023 | Prolaris |
| Seagen INC. | $54.99 | 2025 | |
| Merck Sharp & Dohme LLC | $53.82 | 2025 | Lynparza |
| Procept Biorobotics Corporation | $49.36 | 2025 | |
| Pfizer INC. | $46.80 | 2023-2025 | |
| Olympus America INC. | $39.26 | 2025 | Itind System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $27.72 | 2021 | |
| Myovant Sciences INC. | $27.18 | 2022 | |
| Urovant Sciences INC | $26.53 | 2022 | |
| Telix Pharmaceuticals | $23.85 | 2025 | Illuccix |
| Astellas Pharma US INC | $17.13 | 2023 | Myrbetriq |
| Abbvie INC. | $16.43 | 2021 | |
| Antares Pharma, INC. | $15.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reena Doane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.